The Precision Peptide Company Inc. News Releases

The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch

Tue, 21 Jul 2026 07:00:00 -0400

HighlightsThe Precision Peptide Company's newly launched direct-to-consumer and telehealth platform is now available in all 50 states of the United States.100% U.S.-compounded peptide products are supported through a 503A compounding agreementJuly 23, 2026 is the scheduled FDA advisory committee review date for several peptide substances, including BPC-157; The Precision Peptide Company's compounding, telehealth, compliance and consumer-sales infrastructure is currently in placeThe website...

The Precision Peptide Company Inc. Announces Closing of LIFE Offering of Common Shares

Wed, 15 Jul 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that further to its news release dated June 11, 2026, it has closed its previously announced non-brokered private placement of common shares in the capital of the Company (the "Shares") at a price of $0.50 per Share under the Listed Issuer Financing Exemption (as defined herein) for gross proceeds of $2,000,000 (the "LIFE...

The Precision Peptide Company Inc. Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches

Tue, 14 Jul 2026 07:00:00 -0400

HighlightsReceived full production run of approximately 20,000 BPC-157 transdermal patches, the Company's lead product candidatePatches are manufactured and independently tested in the United StatesMarks the Company's transition from testing to commercializationEach patch delivers 2 mg of BPC-157, consistent with the 95.5% purity and 2.02 mg dose Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a...

The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch

Tue, 07 Jul 2026 14:43:00 -0400

HighlightsThe Precision Peptide Company can now sell its peptide products directly to consumers online across all 50 U.S. states, with its consumer-facing retail telehealth website now liveThe site connects consumers with licensed providers, prescription workflows, and U.S.-based pharmacy fulfillment, bringing the Company's U.S. access pathway onlineAll peptides — including BPC-157 — will be 100% compounded in the United States under the Company's 503A compounding agreementThe Company's...

The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine

Tue, 30 Jun 2026 07:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that its needle-free Recovery Patch, formulated with BPC-157 peptide, will be featured in the June-August 2026 issue of Men's Health magazine.The placement appears in the magazine's "Going Strong" product showcase, alongside a curated...

The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification

Tue, 23 Jun 2026 07:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations, today announced it has been awarded LegitScript Healthcare Merchant Certification - an independent, third-party seal recognizing the Company's compliance, transparency, and consumer-safety standards.The certification is recognized by Visa, Mastercard, Google, Microsoft, and...

The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland

Tue, 16 Jun 2026 07:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that the previously announced episode of The Human Upgrade with Dave Asprey featuring Justin Kirkland, Chief Scientific Officer of the Company, is now available.The episode is live on Apple Podcasts, Spotify, YouTube, and at daveasprey.com....

The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares

Thu, 11 Jun 2026 17:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it intends to undertake a non-brokered private placement of a minimum of 3,000,000 and up to 4,000,000 common shares in the capital of the Company (the "Shares") at a price of $0.50 per Share for minimum gross proceeds of $1,500,000 and up to $2,000,000 (the "Offering").The Offering is being completed pursuant to the listed...

The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership

Tue, 09 Jun 2026 07:30:00 -0400

HighlightsSigned an agreement with a U.S.-based prescription telehealth and infrastructure partner to support compliant prescribing, fulfillment, and delivery of the Company's peptide productsBuilds on the Company's recently announced 503A compounding agreement, under which all peptides -including BPC-157- are to be 100% compounded in the United StatesPartner platform is trusted by more than 100 telehealth brands and is designed to align with U.S. legal, HIPAA, and pharmacy regulationsConnects...

The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC

Fri, 05 Jun 2026 07:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that, further to its news release dated October 15, 2025, it has extended its existing agreement with Emerging Markets Consulting, LLC ("EMC") for the continued provision of investor relations and communication services by EMC for an additional six month term.Emerging Markets Consulting, LLCBased in Orlando, Florida, EMC brings...